Latest news with #ZacksInvestment
Yahoo
3 hours ago
- Business
- Yahoo
First Horizon: Q2 Earnings Snapshot
MEMPHIS, Tenn. (AP) — MEMPHIS, Tenn. (AP) — First Horizon National Corp. (FHN) on Wednesday reported second-quarter earnings of $240 million. The Memphis, Tennessee-based bank said it had earnings of 45 cents per share. The results exceeded Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of 41 cents per share. The bank holding company posted revenue of $1.24 billion in the period. Its revenue net of interest expense was $834 million, also exceeding Street forecasts. Four analysts surveyed by Zacks expected $826.6 million. _____ This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on FHN at Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
16 hours ago
- Business
- Yahoo
3 Medical Stocks to Watch as Q2 Earnings Approach: ABT, JNJ, NVS
Strong Q2 results from banks and other financial firms are starting to highlight this week's earnings lineup, and investors may want to pay attention to several medical companies that are set to report as well. This is especially true, as the S&P 500 and Nasdaq hit new highs on Tuesday, even as June's CPI report began to show tariff-related inflation increases. Hopefully, the indexes will continue to rise, but it's always noteworthy that the medical sector can serve as an effective hedge against broader market volatility. Keeping in mind that healthcare is always essential, regardless of economic fluctuations, here are three medical stocks to consider as their Q2 earnings approach. At the moment, the Zacks Large Cap Pharmaceuticals Industry is in the top 29% of over 240 Zacks industries, and Johnson & Johnson JNJ is a leader in the space to consider. Reporting its Q2 results before market hours on Wednesday, July 16, Johnson & Johnson is benefiting from a pleasant trend of positive earnings estimate revisions over the last 30 days for fiscal 2025 and FY26. This is despite Johnson & Johnson's Q2 EPS being slated to dip 5% to $2.66. Still, JNJ shares trade at a reasonable 14.7X forward earnings multiple, offering sound value as one of the most diversified pharmaceutical companies in the world. Furthermore, JNJ has an enticing 3.32% annual dividend yield that sticks out above the industry average of 2.57% and the benchmark S&P 500's 1.18% average. Image Source: Zacks Investment Research Plus, the pharma giant's bottom line is still projected to expand 6% this year with FY26 EPS forecasted to rise another 4% to $11.09 per share. It's also noteworthy that the Zacks ESP (Expected Surprise Prediction) suggests Johnson & Johnson could surpass earnings expectations with the Most Accurate and recent estimates among Wall Street having Q2 EPS pegged at $2.72, and 2% above the Zacks Consensus. Image Source: Zacks Investment Research Also belonging to the top-rated Zacks Large Cap Pharmaceuticals Industry is Novartis NVS, which will be reporting Q2 results before the opening bell on Thursday, July 17. Like Johnson & Johnson, Novartis has maintained its dominant position as a top pharma company thanks to its diversified portfolio of various drugs, covering core therapeutic areas like cardiovascular, renal and metabolic, immunology, neuroscience, and oncology. Novartis's appealing growth is expected to reflect in its upcoming report, with Q2 sales expected to rise 9% from the prior year quarter to $14.04 billion and EPS projected to spike 21% to $2.38. Magnifying Novartis' outlook is that FY25 EPS estimates are slightly up in the last month, with FY26 EPS estimates rising over 2% from projections of $9.14 to $9.35 per share. Furthermore, NVS trades at an attractive 13.5X forward earnings multiple while offering a very respectable 2.14% annual dividend. Image Source: Zacks Investment Research Rounding out the list of medical stocks to watch this week is Abbott Laboratories ABT. Reporting Q2 results on Thursday morning, Abbott's diversified line of healthcare products extends to pharmaceutical products, diagnostic products, nutritional products, and medical products. On pace to achieve double-digit EPS growth for the foreseeable future, Abbott's Q2 earnings are expected to rise 9% to $1.25 per share (Current Qtr below). The Zacks ESP also indicates Abbott could top earnings expectations, with the Most Accurate estimate having Q2 EPS slightly above the Zacks Consensus at $1.27. Notably, mid to high single-digit top line expansion is in the forecast for Abbott's annual outlook, with Q2 sales thought to have risen nearly 7% to $11.07 billion. Reassuringly, Abbott's 25.6X forward earnings multiple is near its Zacks Medical-Products Industry average, and ABT has a 1.79% annual dividend yield that tops its peers and the benchmark. Image Source: Zacks Investment Research Not to set a bearish tone, but the broader market's historic rebound may make it necessary to consider some defensive positions in the portfolio, and these medical stocks fit the bill ahead of their Q2 reports. Even better, the outlook for Johnson & Johnson, Novartis, and Abbott Laboratories is starting to make their stocks worthy of consideration, even if market volatility doesn't arise soon. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Abbott Laboratories (ABT) : Free Stock Analysis Report Novartis AG (NVS) : Free Stock Analysis Report Johnson & Johnson (JNJ) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
17 hours ago
- Business
- Yahoo
Fulton Financial: Q2 Earnings Snapshot
LANCASTER, Pa. (AP) — LANCASTER, Pa. (AP) — Fulton Financial Corp. (FULT) on Tuesday reported second-quarter earnings of $99.2 million. The bank, based in Lancaster, Pennsylvania, said it had earnings of 53 cents per share. Earnings, adjusted for pretax expenses, were 55 cents per share. The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 43 cents per share. The financial holding company posted revenue of $471.9 million in the period. Its revenue net of interest expense was $328.5 million, also beating Street forecasts. _____ This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on FULT at
Yahoo
19 hours ago
- Business
- Yahoo
Zacks Investment Ideas feature highlights: Nvidia and Micron Technology
Chicago, IL – July 15, 2025– Today, Zacks Investment Ideas feature highlights Nvidia NVDA and Micron Technology MU. Nvidia just hit a staggering $4 trillion market cap, cementing its position as the most dominant force in the AI hardware space. It's an incredible milestone and one that reflects the company's overwhelming leadership in GPUs, data center infrastructure, and the broader AI compute stack. Nvidia remains a compelling long-term investment, and there's little reason to doubt its continued growth as AI adoption expands across industries. However, with Nvidia's stock soaring to such extreme heights, some investors may be wondering: are there other AI stocks with considerable upside opportunity? Micron Technology is a crucial but often underappreciated player in the AI ecosystem. While Nvidia powers the compute side of AI workloads, Micron is a leader in memory and storage and key components that are becoming increasingly critical to support the massive data demands of AI training and inference. This is becoming obvious as Micron's sales and earnings are accelerating higher in recent quarters. As demand surges for high-bandwidth memory (HBM), DRAM, and advanced NAND solutions in AI data centers, Micron stands to benefit in a big way. And with shares still trading at a significant discount to many AI peers and growth forecasts, Micron may represent one of the most asymmetric opportunities in the entire semiconductor space. Despite its massive run and $4 trillion market cap milestone, Nvidia remains a dominant force in the AI and data center ecosystem, and its long-term growth story is far from over. The company continues to lead in AI compute infrastructure, with its GPUs and networking platforms forming the backbone of nearly every major AI deployment—whether in hyperscale cloud, enterprise, or research. The numbers still justify investor enthusiasm: revenue is projected to grow at a robust ~30% annual rate over the next several years, while earnings are expected to rise in lockstep, reflecting Nvidia's industry leadership and exceptional operating leverage. The company's gross margins remain world-class, and its innovation pipeline, from Blackwell chips to next-gen software platforms keeps it at the center of the AI arms race. With shares continuing to print new all-time highs, price momentum is firmly on Nvidia's side. While valuation is elevated by traditional metrics at 39x forward earnings, it is still below its median valuation and with the company's combination of growth, profitability, and unmatched market positioning makes it difficult to bet against, even at these levels. While much of the spotlight in AI has gone to the likes of Nvidia, Micron Technology is quietly emerging as a powerful beneficiaries of the AI infrastructure boom. As a global leader in memory and storage, Micron provides the high-bandwidth DRAM and advanced NAND essential for training and running large AI models. Its leadership in the memory market, where it competes alongside Samsung and SK Hynix, positions the company as a critical supplier in the accelerating data center buildout. Micron's fundamentals are beginning to reflect this momentum. The stock has attracted significant institutional buying year-to-date, and the rebound off the April correction has been particularly strong, signaling a pickup in price momentum and investor conviction. With AI demand surging and memory pricing firming, sales are expected to jump 46% this year and 33% next year, while earnings are projected to surge over 500% this year and grow another 58% in 2026. Although Micron currently holds a Zacks Rank #3 (Hold), it's worth noting that analyst sentiment has turned increasingly bullish, with earnings estimates revised higher by 12% for the current year and 14% for next year. Even with this rapid growth, Micron trades at just 16x forward earnings—a reasonable multiple for a company delivering breakout results in one of the hottest corners of the semiconductor sector. While Nvidia continues to dominate headlines and attract the bulk of investor capital in the AI space, Micron offers a rare combination of explosive earnings growth, improving sentiment, and compelling valuation, all while flying under the radar. Its critical role in supplying the memory infrastructure that underpins AI models puts it in the center of one of the most powerful secular trends in technology today. For investors looking to diversify their AI exposure beyond the obvious names, Micron represents a high-quality, underappreciated way to play the next leg of the AI buildout. From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all. This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months. Free: See Our Top Stock And 4 Runners Up Media Contact Zacks Investment Research 800-767-3771 ext. 9339 support@ Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit information about the performance numbers displayed in this press release. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Micron Technology, Inc. (MU) : Free Stock Analysis Report NVIDIA Corporation (NVDA) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Globe and Mail
a day ago
- Business
- Globe and Mail
Zacks Investment Ideas feature highlights: Nvidia and Micron Technology
For Immediate Release Chicago, IL – July 15, 2025– Today, Zacks Investment Ideas feature highlights Nvidia NVDA and Micron Technology MU. Is NVIDIA Topping Out? Why Micron Might Be the Next AI Winner Nvidia just hit a staggering $4 trillion market cap, cementing its position as the most dominant force in the AI hardware space. It's an incredible milestone and one that reflects the company's overwhelming leadership in GPUs, data center infrastructure, and the broader AI compute stack. Nvidia remains a compelling long-term investment, and there's little reason to doubt its continued growth as AI adoption expands across industries. However, with Nvidia's stock soaring to such extreme heights, some investors may be wondering: are there other AI stocks with considerable upside opportunity? Micron Technology is a crucial but often underappreciated player in the AI ecosystem. While Nvidia powers the compute side of AI workloads, Micron is a leader in memory and storage and key components that are becoming increasingly critical to support the massive data demands of AI training and inference. This is becoming obvious as Micron's sales and earnings are accelerating higher in recent quarters. As demand surges for high-bandwidth memory (HBM), DRAM, and advanced NAND solutions in AI data centers, Micron stands to benefit in a big way. And with shares still trading at a significant discount to many AI peers and growth forecasts, Micron may represent one of the most asymmetric opportunities in the entire semiconductor space. Can Investors Still Buy Nvidia Shares? Despite its massive run and $4 trillion market cap milestone, Nvidia remains a dominant force in the AI and data center ecosystem, and its long-term growth story is far from over. The company continues to lead in AI compute infrastructure, with its GPUs and networking platforms forming the backbone of nearly every major AI deployment—whether in hyperscale cloud, enterprise, or research. The numbers still justify investor enthusiasm: revenue is projected to grow at a robust ~30% annual rate over the next several years, while earnings are expected to rise in lockstep, reflecting Nvidia's industry leadership and exceptional operating leverage. The company's gross margins remain world-class, and its innovation pipeline, from Blackwell chips to next-gen software platforms keeps it at the center of the AI arms race. With shares continuing to print new all-time highs, price momentum is firmly on Nvidia's side. While valuation is elevated by traditional metrics at 39x forward earnings, it is still below its median valuation and with the company's combination of growth, profitability, and unmatched market positioning makes it difficult to bet against, even at these levels. Why Micron Technology Stock Is a Buy While much of the spotlight in AI has gone to the likes of Nvidia, Micron Technology is quietly emerging as a powerful beneficiaries of the AI infrastructure boom. As a global leader in memory and storage, Micron provides the high-bandwidth DRAM and advanced NAND essential for training and running large AI models. Its leadership in the memory market, where it competes alongside Samsung and SK Hynix, positions the company as a critical supplier in the accelerating data center buildout. Micron's fundamentals are beginning to reflect this momentum. The stock has attracted significant institutional buying year-to-date, and the rebound off the April correction has been particularly strong, signaling a pickup in price momentum and investor conviction. With AI demand surging and memory pricing firming, sales are expected to jump 46% this year and 33% next year, while earnings are projected to surge over 500% this year and grow another 58% in 2026. Although Micron currently holds a Zacks Rank #3 (Hold), it's worth noting that analyst sentiment has turned increasingly bullish, with earnings estimates revised higher by 12% for the current year and 14% for next year. Even with this rapid growth, Micron trades at just 16x forward earnings—a reasonable multiple for a company delivering breakout results in one of the hottest corners of the semiconductor sector. Micron Stock is a Non-Consensus AI Opportunity While Nvidia continues to dominate headlines and attract the bulk of investor capital in the AI space, Micron offers a rare combination of explosive earnings growth, improving sentiment, and compelling valuation, all while flying under the radar. Its critical role in supplying the memory infrastructure that underpins AI models puts it in the center of one of the most powerful secular trends in technology today. For investors looking to diversify their AI exposure beyond the obvious names, Micron represents a high-quality, underappreciated way to play the next leg of the AI buildout. Research Chief Names "Single Best Pick to Double" From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all. This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months. Free: See Our Top Stock And 4 Runners Up Media Contact Zacks Investment Research 800-767-3771 ext. 9339 support@ Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit for information about the performance numbers displayed in this press release. 7 Best Stocks for the Next 30 Days Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops." Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.5% per year. So be sure to give these hand picked 7 your immediate attention. See them now >> Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Micron Technology, Inc. (MU): Free Stock Analysis Report
